BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Fuse Science, Inc. Announces 2014 First Quarter Financial Results


2/28/2014 9:42:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MIAMI LAKES, FL--(Marketwired - February 27, 2014) - Fuse Science, Inc. (OTCQB: DROP) (www.fusescience.com), a consumer products and delivery technology company that is developing new, patent-pending technologies working to redefine how consumers receive energy, medicines, vitamins and minerals announced yesterday their financial results for its fiscal 2014 first quarter ended December 31, 2013.

Key Financial Results for the First Quarter Ended December 31, 2013

  • The Company had gross sales of $513,993 and reported net revenue of $313,993 for the quarter ended December 31, 2013 an increase of 671% as compared to net revenue of $40,711 for the prior year quarter-end December 31, 2012.

  • Loss from operations decreased $579,708 to $1,617,006 for the quarter ended December 31, 2013 as compared to $2,196,714 for the quarter period ended December 31, 2012.

  • Excluding non-cash charges, loss from operations decreased $549,927 to $495,737 for the quarter ended December 31, 2013 as compared to $1,045,664 for the quarter ended December 31, 2012.

Brian Tuffin, CEO of Fuse Science, Inc. states, "We continue to focus on the execution of our business plan. The aggressive steps in expense control and targeted execution of our plan has begun to move results in the right direction. We maintain our focus on advancing a series of strategic licensing and commercialization opportunities that we anticipate will be completed shortly. We believe these initiatives will accelerate growth in shareholder value by strengthening both our consumer products business and technology licensing revenue.

A full analysis of results for the period ended December 31, 2013 is available in the Company's Form 10-Q, which is available on the Company's website at www.fusescience.com or within the Filings section of the Securities and Exchange Commission's web site located at www.sec.gov.

To become "Powered By Fuse®", visit your local Walgreens or Duane Reade store or go to www.poweredbyfuse.com.

About Fuse Science, Inc.
Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products and delivery technology company based in Miami Lakes, Florida. Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The Company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly -- all in a concentrated "DROP" form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).

For Fuse Science news as it happens, follow us on Twitter: https://twitter.com/fuse_science

Like Us on Facebook: https://www.facebook.com/FuseScience

Sign up for Fuse Science news updates here: http://ir.stockpr.com/fusescience/email-alerts


For more information:
Fuse Science, Inc.
Investor Relations
Tel: (305) 503-3873, Ext. 2
Email: ir@fusescience.com

To schedule an interview:
Gus DeQuesada
Michelsen Advertising
Tel: (786) 488-7138
Email: prnews@michelsenadvertising.com



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES